Biotech News
Biote Reports Third Quarter 2026 Financial Results
Company maintains 2026 financial outlook Third Quarter 2026 Financial Summary Revenue of $43.3 million Gross profit margin of 67.7% Net income of $0.6 million and diluted earnings per share attributable to biote Corp. stockholders of $0.01 Adjusted EBITDA 1 of $5.1 million and Adjusted EBITDA
